DRUG · Unmapped registry intervention
VTS-K
Find medicine records ·
Find other trials using this name
Clinical trial
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
NCT05615948
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedOral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Treatment Resistant Depressionunresolved
Analgesiaunresolved
Ketamineunresolved
Peripheral Nervous System Agentsunresolved
Central Nervous System Depressantsunresolved
Neurotransmitter Agentsunresolved
Anti-Inflammatory Agentsunresolved
Physiological Effects of Drugsunresolved
Sensory System Agentsunresolved
Analgesics, Non-Narcoticunresolved
Anti-Inflammatory Agents, Non-Steroidalunresolved
Depressive Symptomsunresolved
Interventions
VTS-KDRUG
Sponsors & collaborators
Theresa Jacob, PhD, MPHlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05615948 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.